Join the club for FREE to access the whole archive and other member benefits.

Clinical trials to test a dual-hormone artificial pancreas system

Fully automated diabetes care for people living with type 1 diabetes in the future

23-May-2019

Key points from article :

Beta Bionics partners with Zealand Pharma to test a dual-hormone artificial pancreas system.

Wearable bionic pancreas iLet uses artificial intelligence to deliver insulin and glucagon analogues.

Plans to use dasiglucagon, a ready-to-use glucagon analogue developed by Zealand Pharma.

Home-use-trials to be done on insulin only configuration versus bihormonal configuration.

Effect on glycaemic control, quality of life and treatment satisfaction will be evaluated.

Could pave way to fully automated diabetes care for people living with type 1 diabetes.

Mentioned in this article:

Click on resource name for more details.

Beta Bionics

Medical device company creating solutions for people with diabetes.

Zealand Pharma

Biotechnology company focused on the discovery and development of peptide-based medicines.

Topics mentioned on this page:
Artificial Organs, Diabetes